Tech Company Financing Transactions
PathogenDx Funding Round
Cresco Capital Partners, Altitude Investment Management and Arcadian Fund joined a $7.5 million Series B capital raise for PathogenDx. The round was announced on 10/1/2019.
Transaction Overview
Company Name
Announced On
10/1/2019
Transaction Type
Venture Equity
Amount
$7,500,000
Round
Series B
Investors
Proceeds Purpose
The company intends to use the funds to continue: expanding its technology into food and agriculture testing, while building on its position with current portfolio of domestic and international clients in the cannabis industry.
Company Information
Company Status
Private & Independent
Industry
AgTech
Mailing Address
9375 E. Shea Blvd. 100
Scottsdale, AZ 85260
USA
Scottsdale, AZ 85260
USA
Phone
Website
Email Address
Overview
PathogenDx's(PDx) mission is to deliver disruptive testing technology and solutions to the botanical, food and agricultural testing markets that provide breakthrough simplicity, and cost-effectiveness, at an adaptable scale for both large and small testing facilities.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Milan Patel
Chief Financial Officer
Jeffrey Ryskamp
Chief Operating Officer
Eric Lachance
Chief Scientific Officer
Michael Hogan
VP - Product Management
Carl Yamashiro
VP - Sales
Mary Myers
Browse more venture capital transactions:
Prev: 10/1/2019: Ever/Body venture capital transaction
Next: 10/1/2019: Kenzie Academy venture capital transaction
Share this article
Where The Data Comes From
We do our best to report on funding rounds that are announced publicly. VC investment data records on this site are sourced from publicly available VC deal announcements. The information comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs